Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 ·Status: COMPLETED ·Phase: PHASE3

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

NCT00902954 ·Status: UNKNOWN ·Phase: PHASE3

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

NCT00555477 ·Status: TERMINATED ·Phase: PHASE2

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

NCT00871858 ·Status: COMPLETED ·Phase: PHASE2

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

NCT00921115 ·Status: COMPLETED ·Phase: PHASE2

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Secondary Adjuvant Long Term Study With Arimidex

NCT00295620 ·Status: COMPLETED ·Phase: PHASE3

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

NCT00516698 ·Status: COMPLETED

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

NCT00004205 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

NCT00244959 ·Status: COMPLETED ·Phase: PHASE2

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

NCT00949598 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

NCT04294225 ·Status: COMPLETED ·Phase: PHASE2

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

NCT00727883 ·Status: COMPLETED

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

NCT00053898 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

NCT00357110 ·Status: COMPLETED ·Phase: PHASE2

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

NCT00002646 ·Status: COMPLETED ·Phase: PHASE3

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

NCT00002529 ·Status: COMPLETED ·Phase: PHASE3

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)

NCT00126360 ·Status: UNKNOWN ·Phase: PHASE4